The global directconsumer disease risk and health genetic test industry market is expected to grow at a CAGR of XX% during the forecast period. The growth of this market can be attributed to the increasing awareness about genetic testing among people, which is driving the demand for these tests. Moreover, technological advancements in this field are also contributing to the growth of this market. For instance, in 2018, Illumina launched its new sequencing system called NovaSeqTM that can sequence up to 600 Gb per run and has a throughput of up to 1 million genomes per year. This will help in reducing the cost associated with sequencing DNA and will also increase access to genetic testing for people across different regions.
The global directconsumer disease risk and health genetic test industry market by type includes celiac disease, Parkinson disease, Alzheimer disease; by application includes online and offline; by region includes North America (US), Latin America (Mexico), Europe (UK), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The growth of the Direct-to-consumer Disease Risk and Health Genetic Test Industry is driven by factors such as increasing awareness about genetic testing, rising incidence of chronic diseases, and growing demand for personalized healthcare services.
- Increasing awareness about genetic testing has led to an increase in the number of people who are willing to undergo genetic tests for various reasons such as family history or lifestyle choices that may lead to certain diseases.
- Rising incidence of chronic diseases has led many people to seek out preventive measures through genetic testing which can help them identify their risk factors for developing certain conditions 3) Growing demand for personalized healthcare services has also contributed significantly towards the growth of this industry.
Industry Growth Insights published a new data on “Direct-to-consumer Disease Risk and Health Genetic Test Industry Market”. The research report is titled “Direct-to-consumer Disease Risk and Health Genetic Test Industry Market research by Types (Celiac Disease, Parkinson Disease, Alzheimer Disease, Other), By Applications (Online, Offline), By Players/Companies 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Research Report
By Type
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
By Application
Online, Offline
By Companies
23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Report Segments:
The global Direct-to-consumer Disease Risk and Health Genetic Test Industry market is segmented on the basis of:
Types
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
Highlights of The Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Celiac Disease
- Parkinson Disease
- Alzheimer Disease
- Other
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Direct-to-consumer Disease Risk and Health Genetic Test Industry Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Direct-to-consumer disease risk and health genetic test industry refers to the business of providing genetic tests directly to consumers. These tests can help people learn more about their personal risk for certain diseases, and may also provide information about how best to improve their health.
Some of the major players in the direct-to-consumer disease risk and health genetic test industry market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market - Supply Chain
4.5. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Forecast
4.5.1. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size (000 Units) and Y-o-Y Growth
4.5.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Absolute $ Opportunity
5. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
5.3.1. Celiac Disease
5.3.2. Parkinson Disease
5.3.3. Alzheimer Disease
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
6.3.1. Online
6.3.2. Offline
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share Forecast, 2019-2026
9. North America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
9.4.1. Online
9.4.2. Offline
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
9.7.1. Celiac Disease
9.7.2. Parkinson Disease
9.7.3. Alzheimer Disease
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share Forecast, 2019-2026
10. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
10.4.1. Online
10.4.2. Offline
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
10.7.1. Celiac Disease
10.7.2. Parkinson Disease
10.7.3. Alzheimer Disease
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share Forecast, 2019-2026
11. Europe Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
11.4.1. Online
11.4.2. Offline
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
11.7.1. Celiac Disease
11.7.2. Parkinson Disease
11.7.3. Alzheimer Disease
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share, 2019-2026
12. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
12.4.1. Online
12.4.2. Offline
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
12.7.1. Celiac Disease
12.7.2. Parkinson Disease
12.7.3. Alzheimer Disease
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share, 2019-2026
13. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Application
13.4.1. Online
13.4.2. Offline
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Industry Market Size and Volume Forecast by Type
13.7.1. Celiac Disease
13.7.2. Parkinson Disease
13.7.3. Alzheimer Disease
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Direct-to-consumer Disease Risk and Health Genetic Test Industry Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Direct-to-consumer Disease Risk and Health Genetic Test Industry Market: Market Share Analysis
14.2. Direct-to-consumer Disease Risk and Health Genetic Test Industry Distributors and Customers
14.3. Direct-to-consumer Disease Risk and Health Genetic Test Industry Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 23andMe
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. MyHeritage
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. LabCorp
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Myriad Genetics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ancestry.com
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Quest Diagnostics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Gene By Gene
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. DNA Diagnostics Center
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Invitae
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. IntelliGenetics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Ambry Genetics
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Living DNA
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. EasyDNA
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pathway Genomics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Centrillion Technology
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Xcode
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Color Genomics
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Anglia DNA Services
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. African Ancestry
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Canadian DNA Services
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
